Empowered Funds, LLC Biogen Inc. Transaction History

Empowered Funds, LLC

$5.56 Billion
Q2 2024

A detailed history of Empowered Funds, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Empowered Funds, LLC holds 3,402 shares of BIIB stock, worth $591,233. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,402

Previous 10,394 67.27%

Holding current value

$591,233

Previous $2.24 Million 64.84%

% of portfolio

0.01%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$190.52 - $236.72 $1.33 Million - $1.66 Million	-6,992 Reduced 67.27%	3,402 $788,000
Q1 2024 May 06, 2024	BUY	$212.02 - $267.71 $1.8 Million - $2.27 Million	8,472 Added 440.79%	10,394 $2.24 Million
Q3 2023 Nov 01, 2023	BUY	$253.3 - $285.89 $104,359 - $117,786	412 Added 27.28%	1,922 $493,000
Q2 2023 Jul 27, 2023	BUY	$275.25 - $318.06 $116,155 - $134,221	422 Added 38.79%	1,510 $430,000
Q1 2023 Apr 05, 2023	BUY	$256.56 - $292.34 $279,137 - $318,065	1,088 New	1,088 $302,000
Q2 2021 Aug 04, 2021	SELL	$259.0 - $414.71 $2.88 Million - $4.62 Million	-11,138 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$236.26 - $355.63 $164,673 - $247,874	697 Added 6.68%	11,138 $2.73 Million
Q3 2020 Oct 26, 2020	BUY	$264.77 - $305.71 $364,853 - $421,268	1,378 Added 15.2%	10,441 $2.96 Million
Q2 2020 Jul 16, 2020	BUY	$258.66 - $342.55 $118,207 - $156,545	457 Added 5.31%	9,063 $2.43 Million
Q1 2020 Jul 16, 2020	BUY	$268.85 - $341.04 $573,725 - $727,779	2,134 Added 32.97%	8,606 $2.72 Million
Q1 2020 Apr 16, 2020	SELL	$268.85 - $341.04 $573,725 - $727,779	-2,134 Reduced 24.8%	6,472 $2.05 Million
Q4 2019 Jan 27, 2020	SELL	$220.06 - $304.07 $258,570 - $357,282	-1,175 Reduced 12.01%	8,606 $2.55 Million
Q3 2019 Nov 01, 2019	BUY	$217.44 - $243.88 $58,708 - $65,847	270 Added 2.84%	9,781 $2.28 Million
Q2 2019 Jul 09, 2019	BUY	$219.29 - $241.72 $2.09 Million - $2.3 Million	9,511 New	9,511 $2.22 Million
Q3 2018 Oct 18, 2018	SELL	$293.51 - $383.83 $3 Million - $3.92 Million	-10,225 Closed	0 $0
Q2 2018 Jul 09, 2018	SELL	$257.52 - $306.91 $271,168 - $323,176	-1,053 Reduced 9.34%	10,225 $2.95 Million
Q1 2018 Apr 25, 2018	BUY	$260.13 - $367.91 $2.93 Million - $4.15 Million	11,278 New	11,278 $3.07 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.

Account

Empowered Funds, LLC Biogen Inc. Transaction History